Mechanisms regulating increased production of osteoprotegerin by osteoblasts cultured on microstructured titanium surfaces

Biomaterials

Volumn 30, Issue 20, 2009, Pages 3390-3396

  Schwartz, Zvi ^a   Olivares Navarrete, Rene ^a   Wieland, Marco ^b   Cochran, David L ^c   Boyan, Barbara D ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b INSTITUT STRAUMANN AG   (Switzerland)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Microtopography; Osteoblast; Osteoprotegerin; TGF 1; Titanium

Indexed keywords

BONE FORMATIONS; BONE REMODELING; CHELERYTHRINE; DOSE-DEPENDENT MANNERS; ETCHED SURFACES; HUMAN OSTEOBLAST LIKES; INTEGRIN; MG63 CELLS; MICROTOPOGRAPHY; OSTEOINTEGRATION; OSTEOPROTEGERIN; PRE TREATMENTS; RANK LIGANDS; SPRAYED SURFACES; STIMULATORY EFFECTS; SURFACE ENERGIES; SURFACE MICROSTRUCTURES; TITANIUM DISKS; TITANIUM SURFACES; TYPE II;

BONE; CELL CULTURE; HEAT SHIELDING; LIGHT WEIGHT ROLLING STOCK; OCEAN CURRENTS; OSTEOBLASTS; SIGNALING; SURFACE CHEMISTRY; SURFACE TENSION; TITANIUM;

SUBSTRATES;

ALPHA2 INTEGRIN; BLOCKING ANTIBODY; CHELERYTHRINE; OSTEOPROTEGERIN; PROTEIN KINASE C; SHORT HAIRPIN RNA; TITANIUM; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; VERY LATE ACTIVATION ANTIGEN 2;

ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MORPHOLOGY; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RECEPTOR BINDING; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; SURFACE CHARGE; SURFACE PROPERTY;

BIOCOMPATIBLE MATERIALS; CELL CULTURE TECHNIQUES; CELL LINE; HUMANS; INTEGRIN ALPHA2BETA1; MATERIALS TESTING; OSTEOBLASTS; OSTEOPROTEGERIN; PROTEIN KINASE C; SIGNAL TRANSDUCTION; SURFACE PROPERTIES; TITANIUM; TRANSFORMING GROWTH FACTOR BETA1;

EID: 67349122805     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.03.047     Document Type: Article

References (39)

1. Schwartz Z., Lohmann C.H., Oefinger J., Bonewald L.F., Dean D.D., and Boyan B.D. Implant surface characteristics modulate differentiation behavior of cells in the osteoblastic lineage. Adv Dent Res 13 (1999) 38-48
2. Boyan B.D., Lossdorfer S., Wang L., Zhao G., Lohmann C.H., Cochran D.L., et al. Osteoblasts generate an osteogenic microenvironment when grown on surfaces with rough microtopographies. Eur Cell Mater 24 (2003) 22-27
3. Schwartz Z., and Boyan B.D. Underlying mechanisms at the bone-biomaterial interface. J Cell Biochem 56 (1994) 340-347
4. Kim C.H., You L., Yellowley C.E., and Jacobs C.R. Oscillatory fluid flow-induced shear stress decreases osteoclastogenesis through RANKL and OPG signaling. Bone 39 (2006) 1043-1047
5. 3. J Bone Miner Res 15 (2000) 1169-1180
6. Martin J.Y., Dean D.D., Cochran D.L., Simpson J., Boyan B.D., and Schwartz Z. Proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63) cultured on previously used titanium surfaces. Clin Oral Implants Res 7 (1996) 27-37
7. 3. J Biomed Mater Res 39 (1998) 77-85
8. Mundy G.R. The effects of TGF-β on bone. Ciba Found Symp 157 (1991) 137-151
9. 3 is mediated via protein kinase C- and protein kinase A-dependent pathways. Biomaterials 22 (2001) 731-741
10. Hofmann A., Ritz U., Verrier S., Eglin D., Alini M., Fuchs S., et al. The effect of human osteoblasts on proliferation and neo-vessel formation of human umbilical vein endothelial cells in a long-term 3D co-culture on polyurethane scaffolds. Biomaterials 29 (2008) 4217-4226
11. Boyce B.F., and Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 473 (2008) 139-146
12. Lossdorfer S., Schwartz Z., Wang L., Lohmann C.H., Turner J.D., Wieland M., et al. Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity. J Biomed Mater Res A 70 (2004) 361-369
13. Cochran D.L., Buser D., ten Bruggenkate C.M., Weingart D., Taylor T.M., Bernard J.P., et al. The use of reduced healing times on ITI implants with a sandblasted and acid-etched (SLA) surface: early results from clinical trials on ITI SLA implants. Clin Oral Implants Res 13 (2002) 144-153
14. Schwartz Z., Raz P., Zhao G., Barak Y., Tauber M., Yao H., et al. Effect of micrometer scale roughness of the surface of Ti6Al4V pedicle screws in vitro and in vivo. J Bone Joint Surg 90 (2008) 2485-2498
15. Raz P., Lohmann C.H., Turner J., Wang L., Poythress N., Blanchard C., et al. 1α,25(OH)2D3 Regulation of integrin expression is substrate dependent. J Biomed Mater Res A 71 (2004) 217-225
16. Wang L., Zhao G., Olivares-Navarrete R., Bell B.F., Wieland M., Cochran D.L., et al. Integrin beta-1 silencing in osteoblasts alters substrate-dependent responses to 1,25-dihydroxy vitamin D3. Biomaterials 27 (2006) 3716-3725
17. Olivares-Navarrete R., Raz P., Zhao G., Wieland M., Cochran D.L., Chaudhri R.A., et al. Integrin α2β1 plays a critical role in the response of osteoblasts to micron scale surface structure and surface energy of titanium substrates. Proc Natl Acad Sci U S A 105 (2008) 15767-15772
18. Sisk M., Lohmann C.H., Cochran D.L., Sylvia V.L., Simpson J.P., Dean D.D., et al. Inhibition of cyclooxygenase by indomethacin modulates osteoblast response to titanium surface roughness in a time-dependent manner. Clin Oral Implants Res 12 (2001) 52-61
19. Boyan B.D., Lohmann C.H., Sisk M., Liu Y., Sylvia V.L., Cochran D.L., et al. Both cyclooxygenase-1 and cyclooxygenase-2 mediate osteoblast response to titanium surface roughness. J Biomed Mater Res 55 (2001) 350-359
20. Bonewald L., Schwartz Z., Swain L.D., Ramirez V., Poser J., and Boyan B.D. Stimulation of plasma membrane and matrix vesicle enzyme activity by transforming growth factor-beta in osteosarcoma cell cultures. J Cell Physiol 145 (1990) 200-206
21. Lawrence D.A. Transforming growth factor-beta: a general review. Eur Cytokine Netw 7 (1996) 363-374
22. 3 on differentiation of a human osteosarcoma (MG-63). J Biol Chem 267 (1992) 8943-8949
23. Gingery A., Bradley E.W., Pederson L., Ruan M., Horwood N.J., and Oursler M.J. TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival. Exp Cell Res 314 (2008) 2725-2738
24. Pivonka P., Zimak J., Smith D.W., Gardiner B.S., Dunstan C.R., Sims N.A., et al. Model structure and control of bone remodeling: a theoretical study. Bone 43 (2008) 249-263
25. Kanzaki H., Chiba M., Sato A., Miyagawa A., Arai K., Nukatsuka S., et al. Cyclical tensile force on periodontal ligament cells inhibits osteoclastogenesis through OPG induction. J Dent Res 85 (2006) 457-462
26. 3 responsive alkaline phosphatase in osteoblast-like cells (ROS 17/2.8, MG 63, and MC 3T3) and growth cartilage cells in culture. J Biol Chem 264 (1989) 11879-11886
27. Palcy S., Bolivar I., and Goltzman D. Role of activator protein 1 transcriptional activity in the regulation of gene expression by transforming growth factor beta1 and bone morphogenetic protein 2 in ROS 17/2.8 osteoblast-like cells. J Bone Miner Res 15 (2000) 2352-2361
28. Miyazono K. TGF-beta signaling by Smad proteins. Cytokine Growth Factor Rev 11 (2000) 15-22
29. Kassem M., Kveiborg M., and Eriksen E.F. Production and action of transforming growth factor-beta in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol. Eur J Clin Invest 30 (2000) 429-437
30. Baldock P.A., Thomas G.P., Hodge J.M., Baker S.U., Dressel U., O'Loughlin P.D., et al. Vitamin D action and regulation of bone remodeling: suppression of osteoclastogenesis by the mature osteoblast. J Bone Miner Res 21 (2006) 1618-1626
31. Kieswetter K., Schwartz Z., Hummert T.W., Cochran D.L., Simpson J., Dean D.D., et al. Surface roughness modulates the local production of growth factors and cytokines by osteoblast-like MG63 cells. J Biomed Mater Res 32 (1996) 55-63
32. Karst M., Gorny G., Galvin R.J., and Oursler M.J. Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation. J Cell Physiol 200 (2004) 99-106
33. Keselowsky B.G., Wang L., Schwartz Z., Garcia A.J., and Boyan B.D. Integrin alpha(5) controls osteoblastic proliferation and differentiation responses to titanium substrates presenting different roughness characteristics in a roughness independent manner. J Biomed Mater Res A 80 (2007) 700-710
34. Gurlek A., Pittelkow M.R., and Kumar R. Modulation of growth factor/cytokine synthesis and signaling by 1alpha,25-dihydroxyvitamin D(3): implications in cell growth and differentiation. Endocr Rev 23 (2002) 763-786
35. Aubin J.E., and Bonnelye E. Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption. Medscape Womens Health 5 (2000) 5
36. Caetano-Lopes J., Canhao H., and Fonseca J.E. Osteoblasts and bone formation. Acta Reumatol Port 32 (2007) 103-110
37. Bernardi B., Guidetti G.F., Campus F., Crittenden J.R., Graybiel A.M., Balduini C., et al. The small GTPase Rap1b regulates the cross talk between platelet integrin alpha2beta1 and integrin alphaIIbbeta3. Blood 107 (2006) 2728-2735
38. 2 activity and activation of protein kinase A. J Biomed Mater Res 47 (1999) 139-151
39. 2. Biomaterials 20 (1999) 2305-2310